Growth Metrics

Quest Diagnostics (DGX) Free Cash Flow (2016 - 2026)

Quest Diagnostics' Free Cash Flow history spans 18 years, with the latest figure at $164.0 million for Q1 2026.

  • On a quarterly basis, Free Cash Flow fell 16.75% to $164.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $1.3 billion, a 25.57% increase, with the full-year FY2025 number at $1.4 billion, up 49.5% from a year prior.
  • Free Cash Flow hit $164.0 million in Q1 2026 for Quest Diagnostics, down from $307.0 million in the prior quarter.
  • Over the last five years, Free Cash Flow for DGX hit a ceiling of $455.0 million in Q4 2023 and a floor of -$33.0 million in Q1 2023.
  • Historically, Free Cash Flow has averaged $271.2 million across 5 years, with a median of $307.0 million in 2025.
  • Biggest five-year swings in Free Cash Flow: crashed 107.91% in 2023 and later soared 294.0% in 2025.
  • Tracing DGX's Free Cash Flow over 5 years: stood at $187.0 million in 2022, then surged by 143.32% to $455.0 million in 2023, then dropped by 25.05% to $341.0 million in 2024, then decreased by 9.97% to $307.0 million in 2025, then plummeted by 46.58% to $164.0 million in 2026.
  • Business Quant data shows Free Cash Flow for DGX at $164.0 million in Q1 2026, $307.0 million in Q4 2025, and $419.0 million in Q3 2025.